Meyer, T.(1999). A derivative of staurosporine (CGP 41: 251) shows selectivity for PKC inhibition and in vitro antiproliferative effects as well as in vivo antitumor activity. Int. J. Cancer, 43, 851–866 (1989). International Journal of Cancer, 81(4), 669-669. doi:10.1002/(sici)1097-0215(19990517)81:4<669::aid-ijc26>3.3.co;2-6

Meyer, T. "A Derivative of Staurosporine (CGP 41: 251) Shows Selectivity for PKC Inhibition and in Vitro Antiproliferative Effects As Well As in Vivo Antitumor Activity. Int. J. Cancer, 43, 851–866 (1989)". International Journal of Cancer, 81.4 ( 1999 ): 669-669.